Kelly E. Dunn, Ph.D. - Publications

Affiliations: 
Johns Hopkins University, Baltimore, MD 

70 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Strickland JC, Huhn AS, Bergeria CL, Strain EC, Dunn KE. Provider Continuity in the Prescribing of Buprenorphine/Naloxone Within Medicare Part D. Journal of Addiction Medicine. PMID 33156180 DOI: 10.1097/ADM.0000000000000765  0.6
2020 Huhn AS, Dunn KE. Challenges for Women Entering Treatment for Opioid Use Disorder. Current Psychiatry Reports. 22: 76. PMID 33128093 DOI: 10.1007/s11920-020-01201-z  0.44
2020 Huhn AS, Brooner RK, Sweeney MM, Antoine D, Hammond AS, Ayaz H, Dunn KE. The association of prefrontal cortex response during a natural reward cue-reactivity paradigm, anhedonia, and demoralization in persons maintained on methadone. Addictive Behaviors. 113: 106673. PMID 33022538 DOI: 10.1016/j.addbeh.2020.106673  0.44
2020 Antoine D, Huhn AS, Strain EC, Turner G, Jardot J, Hammond AS, Dunn KE. Method for Successfully Inducting Individuals Who Use Illicit Fentanyl Onto Buprenorphine/Naloxone. The American Journal On Addictions. PMID 32572978 DOI: 10.1111/ajad.13069  0.6
2020 Bergeria CL, Huhn AS, Dunn KE. The impact of naturalistic cannabis use on self-reported opioid withdrawal. Journal of Substance Abuse Treatment. 113: 108005. PMID 32359667 DOI: 10.1016/j.jsat.2020.108005  0.44
2020 Bergeria CL, Dolan SB, Johnson MW, Campbell CM, Dunn KE. Evaluating the co-use of opioids and cannabis for pain among current users using hypothetical purchase tasks. Journal of Psychopharmacology (Oxford, England). 269881120914211. PMID 32267192 DOI: 10.1177/0269881120914211  0.44
2020 Huhn AS, Hobelmann JG, Strickland JC, Oyler GA, Bergeria CL, Umbricht A, Dunn KE. Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States. Jama Network Open. 3: e1920843. PMID 32031650 DOI: 10.1001/jamanetworkopen.2019.20843  0.52
2020 Garcia-Romeu A, Cox DJ, Smith KE, Dunn KE, Griffiths RR. Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic. Drug and Alcohol Dependence. 107849. PMID 32029298 DOI: 10.1016/j.drugalcdep.2020.107849  0.44
2019 Dunn KE, Huhn AS, Strain EC. Differential adoption of opioid agonist treatments in detoxification and outpatient settings. Journal of Substance Abuse Treatment. 107: 24-28. PMID 31757261 DOI: 10.1016/j.jsat.2019.10.002  0.6
2019 Dunn KE, Barrett FS, Brands B, Marsh DC, Bigelow GE. Individual differences in human opioid abuse potential as observed in a human laboratory study. Drug and Alcohol Dependence. 205: 107688. PMID 31710994 DOI: 10.1016/j.drugalcdep.2019.107688  0.64
2019 Huhn AS, Brooner RK, Sweeney MM, Yip SW, Ayaz H, Dunn KE. Increased neural activity in the right dorsolateral prefrontal cortex during a risky decision-making task is associated with cocaine use in methadone-maintained patients. Drug and Alcohol Dependence. 205: 107650. PMID 31669801 DOI: 10.1016/j.drugalcdep.2019.107650  0.44
2019 Dunn KE, Bergeria CL, Huhn AS, Strain EC. A Systematic Review of Laboratory Evidence for the Abuse Potential of Tramadol in Humans. Frontiers in Psychiatry. 10: 704. PMID 31616329 DOI: 10.3389/fpsyt.2019.00704  0.6
2019 Dunn KE, Huhn AS, Bergeria CL, Gipson CD, Weerts EM. Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence. The Journal of Pharmacology and Experimental Therapeutics. PMID 31391211 DOI: 10.1124/jpet.119.258004  0.44
2019 Hammond AS, Dunn KE, Strain EC. Drug Legalization and Decriminalization Beliefs Among Substance-using and Nonusing Individuals. Journal of Addiction Medicine. PMID 31385846 DOI: 10.1097/ADM.0000000000000542  0.6
2019 Bergeria CL, Huhn AS, Tompkins DA, Bigelow GE, Strain EC, Dunn KE. The relationship between pupil diameter and other measures of opioid withdrawal during naloxone precipitated withdrawal. Drug and Alcohol Dependence. 202: 111-114. PMID 31336328 DOI: 10.1016/j.drugalcdep.2019.05.010  0.64
2019 Huhn AS, Berry MS, Dunn KE. Review: Sex-Based Differences in Treatment Outcomes for Persons With Opioid Use Disorder. The American Journal On Addictions. PMID 31131505 DOI: 10.1111/ajad.12921  0.44
2019 Bergeria CL, Huhn AS, Dunn KE. Randomized comparison of two web-based interventions on immediate and 30-day opioid overdose knowledge in three unique risk groups. Preventive Medicine. PMID 31078564 DOI: 10.1016/j.ypmed.2019.05.006  0.44
2019 Huhn AS, Tompkins DA, Campbell CM, Dunn KE. Individuals with Chronic Pain Who Misuse Prescription Opioids Report Sex-Based Differences in Pain and Opioid Withdrawal. Pain Medicine (Malden, Mass.). PMID 30690594 DOI: 10.1093/pm/pny295  0.44
2019 Hay KR, Huhn AS, Tompkins DA, Dunn KE. Recovery Goals and Long-term Treatment Preference in Persons Who Engage in Nonmedical Opioid Use. Journal of Addiction Medicine. PMID 30633045 DOI: 10.1097/ADM.0000000000000498  0.44
2018 Huhn AS, Berry MS, Dunn KE. Systematic review of sex-based differences in opioid-based effects. International Review of Psychiatry (Abingdon, England). 1-10. PMID 30522374 DOI: 10.1080/09540261.2018.1514295  0.44
2018 Falk DE, Ryan ML, Fertig JB, Devine EG, Cruz R, Brown ES, Burns H, Salloum IM, Newport DJ, Mendelson J, Galloway G, Kampman K, Brooks C, Green AI, Brunette MF, ... ... Dunn KE, et al. Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial assessing Efficacy and Safety. Alcoholism, Clinical and Experimental Research. PMID 30403402 DOI: 10.1111/acer.13917  0.6
2018 Huhn AS, Strain EC, Tompkins DA, Dunn KE. A hidden aspect of the U.S. opioid crisis: Rise in first-time treatment admissions for older adults with opioid use disorder. Drug and Alcohol Dependence. 193: 142-147. PMID 30384321 DOI: 10.1016/j.drugalcdep.2018.10.002  0.6
2018 Huhn AS, Sweeney MM, Brooner K, Kidorf MS, Tompkins DA, Ayaz H, Dunn KE. Prefrontal cortex Response to Drug cues, craving, and current depressive symptoms are associated with treatment outcomes in methadone-maintained patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30375498 DOI: 10.1038/s41386-018-0252-0  0.44
2018 Dunn KE, Weerts EM, Huhn AS, Schroeder JR, Tompkins DA, Bigelow GE, Strain EC. Preliminary evidence of different and clinically meaningful opioid withdrawal phenotypes. Addiction Biology. PMID 30295400 DOI: 10.1111/adb.12680  0.64
2018 Dunn KE, Barrett FS, Bigelow GE. Naloxone formulation for overdose reversal preference among patients receiving opioids for pain management. Addictive Behaviors. PMID 29625751 DOI: 10.1016/j.addbeh.2018.03.011  0.64
2018 Huhn AS, Garcia-Romeu AP, Dunn KE. Opioid Overdose Education for Individuals Prescribed Opioids for Pain Management: Randomized Comparison of Two Computer-Based Interventions. Frontiers in Psychiatry. 9: 34. PMID 29483884 DOI: 10.3389/fpsyt.2018.00034  0.44
2017 Dunn KE, Tompkins DA, Strain EC. Tramadol Extended-Release and Opioid Withdrawal Management-Legal Implications-Reply. Jama Psychiatry. PMID 29282473 DOI: 10.1001/jamapsychiatry.2017.3827  0.6
2017 Dunn KE, Brands B, Marsh DC, Bigelow GE. Characterizing the subjective, observer-rated, and physiological effects of hydromorphone relative to heroin in a human laboratory study. Psychopharmacology. PMID 29270641 DOI: 10.1007/s00213-017-4814-3  0.64
2017 Dunn KE, Brands B, Marsh DC, Bigelow GE. Characterizing the subjective, observer-rated, and physiological effects of hydromorphone relative to heroin in a human laboratory study. Psychopharmacology. PMID 29270641 DOI: 10.1007/s00213-017-4814-3  0.64
2017 Dunn KE, Brands B, Marsh DC, Bigelow GE. Characterizing the subjective, observer-rated, and physiological effects of hydromorphone relative to heroin in a human laboratory study. Psychopharmacology. PMID 29270641 DOI: 10.1007/s00213-017-4814-3  0.64
2017 Huhn AS, Tompkins DA, Dunn KE. The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use. Drug and Alcohol Dependence. 180: 279-285. PMID 28942031 DOI: 10.1016/j.drugalcdep.2017.08.019  0.44
2017 Dunn KE, Finan PH, Andrew Tompkins D, Strain EC. Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patients. Addictive Behaviors. 76: 8-14. PMID 28735039 DOI: 10.1016/j.addbeh.2017.07.016  0.6
2017 Dunn KE, Tompkins DA, Bigelow GE, Strain EC. Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial. Jama Psychiatry. PMID 28700791 DOI: 10.1001/jamapsychiatry.2017.1838  0.64
2017 Huhn AS, Dunn KE. Why aren't physicians prescribing more buprenorphine? Journal of Substance Abuse Treatment. 78: 1-7. PMID 28554597 DOI: 10.1016/j.jsat.2017.04.005  0.44
2017 Dunn KE, Yepez-Laubach C, Nuzzo PA, Fingerhood M, Kelly A, Berman S, Bigelow GE. Randomized controlled trial of a computerized opioid overdose education intervention. Drug and Alcohol Dependence. 173: S39-S47. PMID 28363318 DOI: 10.1016/j.drugalcdep.2016.12.003  0.64
2016 Jarvis BP, Holtyn AF, DeFulio A, Dunn KE, Everly JJ, Leoutsakos JS, Umbricht A, Fingerhood M, Bigelow GE, Silverman K. Effects of incentives for naltrexone adherence on opiate abstinence in heroin-dependent adults. Addiction (Abingdon, England). PMID 27936293 DOI: 10.1111/add.13724  0.64
2016 Dunn KE, Barrett FS, Yepez-Laubach C, Meyer AC, Hruska BJ, Petrush K, Berman S, Sigmon SC, Fingerhood M, Bigelow GE. Opioid Overdose Experience, Risk Behaviors, and Knowledge in Drug Users from a Rural versus an Urban Setting. Journal of Substance Abuse Treatment. 71: 1-7. PMID 27672239 DOI: 10.1016/j.jsat.2016.08.006  0.72
2016 Ryan ML, Falk DE, Fertig JB, Rendenbach-Mueller B, Katz DA, Tracy KA, Strain EC, Dunn KE, Kampman K, Mahoney E, Ciraulo DA, Sickles-Colaneri L, Ait-Daoud N, Johnson BA, Ransom J, et al. A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27658483 DOI: 10.1038/npp.2016.214  0.6
2016 Dunn KE, Barrett FS, Fingerhood M, Bigelow GE. Opioid Overdose History, Risk Behaviors, and Knowledge in Patients Taking Prescribed Opioids for Chronic Pain. Pain Medicine (Malden, Mass.). PMID 27651504 DOI: 10.1093/pm/pnw228  0.64
2016 Dunn KE, Barrett FS, Herrmann ES, Plebani JG, Sigmon SC, Johnson MW. Behavioral risk assessment for infectious diseases (BRAID): Self-report instrument to assess injection and noninjection risk behaviors in substance users. Drug and Alcohol Dependence. 168: 69-75. PMID 27615403 DOI: 10.1016/j.drugalcdep.2016.07.032  0.72
2016 Dunn KE, Harrison JA, Leoutsakos JM, Han D, Strain EC. Continuous Abstinence During Early Alcohol Treatment is Significantly Associated with Positive Treatment Outcomes, Independent of Duration of Abstinence. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 27567268 DOI: 10.1093/alcalc/agw059  0.6
2016 Dunn KE, Barrett FS, Yepez-Laubach C, Meyer AC, Hruska BJ, Sigmon SC, Fingerhood M, Bigelow GE. Brief Opioid Overdose Knowledge (BOOK): A Questionnaire to Assess Overdose Knowledge in Individuals Who Use Illicit or Prescribed Opioids. Journal of Addiction Medicine. PMID 27504923 DOI: 10.1097/ADM.0000000000000235  0.72
2016 Dunn KE, Barrett FS, Yepez-Laubach C, Meyer AC, Hruska BJ, Petrush K, Berman S, Sigmon SC, Fingerhood M, Bigelow GE. Opioid overdose experience, risk behaviors, and knowledge in drug users from a rural versus an urban setting Journal of Substance Abuse Treatment. 71: 1-7. DOI: 10.1016/j.jsat.2016.08.006  0.72
2015 Kiluk BD, Carroll KM, Duhig A, Falk DE, Kampman K, Lai S, Litten RZ, McCann DJ, Montoya ID, Preston KL, Skolnick P, Weisner C, Woody G, Chandler R, Detke MJ, ... Dunn K, et al. Measures of outcome for stimulant trials: ACTTION recommendations and research agenda. Drug and Alcohol Dependence. PMID 26652899 DOI: 10.1016/j.drugalcdep.2015.11.004  0.6
2015 Dunn KE, Finan PH, Tompkins DA, Fingerhood M, Strain EC. Characterizing pain and associated coping strategies in methadone and buprenorphine-maintained patients. Drug and Alcohol Dependence. PMID 26518253 DOI: 10.1016/j.drugalcdep.2015.10.018  0.64
2015 Dunn K, Marcus T, Kim C, Schroeder JR, Vandrey R, Umbricht A. Zonisamide Reduces Withdrawal Symptoms But Does Not Enhance Varenicline-induced Smoking Cessation. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 26476459 DOI: 10.1093/ntr/ntv236  0.72
2015 Dunn KE, Ashley EA. Arrhythmogenic Right Ventricular Cardiomyopathy: Toward a Modern Clinical and Genomic Understanding. Circulation. Cardiovascular Genetics. 8: 421-4. PMID 26082552 DOI: 10.1161/CIRCGENETICS.115.001119  0.44
2015 Dunn KE, Saulsgiver KA, Miller ME, Nuzzo PA, Sigmon SC. Characterizing opioid withdrawal during double-blind buprenorphine detoxification. Drug and Alcohol Dependence. 151: 47-55. PMID 25823907 DOI: 10.1016/j.drugalcdep.2015.02.033  0.72
2015 Dunn K, DeFulio A, Everly JJ, Donlin WD, Aklin WM, Nuzzo PA, Leoutsakos JM, Umbricht A, Fingerhood M, Bigelow GE, Silverman K. Employment-based reinforcement of adherence to oral naltrexone in unemployed injection drug users: 12-month outcomes. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 29: 270-6. PMID 25134047 DOI: 10.1037/adb0000010  0.72
2014 Patrick ME, Dunn KE, Badger GJ, Heil SH, Higgins ST, Sigmon SC. Spontaneous reductions in smoking during double-blind buprenorphine detoxification. Addictive Behaviors. 39: 1353-6. PMID 24845165 DOI: 10.1016/j.addbeh.2014.04.023  0.72
2014 Dunn KE, Brooner RK, Clark MR. Severity and interference of chronic pain in methadone-maintained outpatients. Pain Medicine (Malden, Mass.). 15: 1540-8. PMID 24703517 DOI: 10.1111/pme.12430  0.72
2014 Dunn KE, Fingerhood M, Wong CJ, Svikis DS, Nuzzo P, Silverman K. Employment-based abstinence reinforcement following inpatient detoxification in HIV-positive opioid and/or cocaine-dependent patients. Experimental and Clinical Psychopharmacology. 22: 75-85. PMID 24490712 DOI: 10.1037/a0034863  0.72
2014 McClure EA, Acquavita SP, Dunn KE, Stoller KB, Stitzer ML. Characterizing smoking, cessation services, and quit interest across outpatient substance abuse treatment modalities. Journal of Substance Abuse Treatment. 46: 194-201. PMID 23988192 DOI: 10.1016/j.jsat.2013.07.009  0.72
2013 Sigmon SC, Dunn KE, Saulsgiver K, Patrick ME, Badger GJ, Heil SH, Brooklyn JR, Higgins ST. A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers. Jama Psychiatry. 70: 1347-54. PMID 24153411 DOI: 10.1001/jamapsychiatry.2013.2216  0.72
2013 Dunn KE, Saulsgiver KA, Patrick ME, Heil SH, Higgins ST, Sigmon SC. Characterizing and improving HIV and hepatitis knowledge among primary prescription opioid abusers. Drug and Alcohol Dependence. 133: 625-32. PMID 24051063 DOI: 10.1016/j.drugalcdep.2013.08.007  0.72
2013 Dunn KE, Strain EC. Pretreatment alcohol drinking goals are associated with treatment outcomes Alcoholism: Clinical and Experimental Research. 37: 1745-1752. PMID 23800222 DOI: 10.1111/acer.12137  0.72
2013 Litten RZ, Ryan ML, Fertig JB, Falk DE, Johnson B, Dunn KE, Green AI, Pettinati HM, Ciraulo DA, Sarid-Segal O, Kampman K, Brunette MF, Strain EC, Tiouririne NA, Ransom J, et al. A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence. Journal of Addiction Medicine. 7: 277-86. PMID 23728065 DOI: 10.1097/ADM.0b013e31829623f4  0.72
2013 Dunn KE, Caleshu C, Cirino AL, Ho CY, Ashley EA. A clinical approach to inherited hypertrophy: the use of family history in diagnosis, risk assessment, and management. Circulation. Cardiovascular Genetics. 6: 118-31. PMID 23424256 DOI: 10.1161/CIRCGENETICS.110.959387  0.44
2013 Dunn KE, Defulio A, Everly JJ, Donlin WD, Aklin WM, Nuzzo PA, Leoutsakos JM, Umbricht A, Fingerhood M, Bigelow GE, Silverman K. Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users. Experimental and Clinical Psychopharmacology. 21: 74-83. PMID 23205722 DOI: 10.1037/a0030743  0.72
2013 Herrmann ES, Heil SH, Sigmon SC, Dunn KE, Washio Y, Higgins ST. Characterizing and improving HIV/AIDS knowledge among cocaine-dependent outpatients using modified materials. Drug and Alcohol Dependence. 127: 220-5. PMID 22889696 DOI: 10.1016/j.drugalcdep.2012.07.006  0.72
2012 Pan S, Caleshu CA, Dunn KE, Foti MJ, Moran MK, Soyinka O, Ashley EA. Cardiac structural and sarcomere genes associated with cardiomyopathy exhibit marked intolerance of genetic variation. Circulation. Cardiovascular Genetics. 5: 602-10. PMID 23074333 DOI: 10.1161/CIRCGENETICS.112.963421  0.44
2012 Vandrey R, Dunn KE, Fry JA, Girling ER. A survey study to characterize use of Spice products (synthetic cannabinoids) Drug and Alcohol Dependence. 120: 238-241. PMID 21835562 DOI: 10.1016/j.drugalcdep.2011.07.011  0.72
2011 Dunn KE, Sigmon SC, Strain EC, Heil SH, Higgins ST. The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: a review. Drug and Alcohol Dependence. 119: 1-9. PMID 21741781 DOI: 10.1016/j.drugalcdep.2011.05.033  0.72
2011 Dunn KE, Saulsgiver KA, Sigmon SC. Contingency Management for Behavior Change: Applications to Promote Brief Smoking Cessation Among Opioid-Maintained Patients Experimental and Clinical Psychopharmacology. 19: 20-30. PMID 21341920 DOI: 10.1037/a0022039  0.72
2010 Dunn KE, Sigmon SC, Reimann EF, Badger GJ, Heil SH, Higgins ST. A contingency-management intervention to promote initial smoking cessation among opioid-maintained patients. Experimental and Clinical Psychopharmacology. 18: 37-50. PMID 20158293 DOI: 10.1037/a0018649  0.72
2009 Dunn KE, Sigmon SC, Reimann E, Heil SH, Higgins ST. Effects of Smoking Cessation on Illicit Drug Use among Opioid Maintenance Patients: A Pilot Study. Journal of Drug Issues. 39: 313-328. PMID 20401340  0.72
2009 Sigmon SC, Dunn KE, Badger GJ, Heil SH, Higgins ST. Brief buprenorphine detoxification for the treatment of prescription opioid dependence: a pilot study. Addictive Behaviors. 34: 304-11. PMID 19081679 DOI: 10.1016/j.addbeh.2008.11.017  0.72
2009 Dunn KE, Sigmon SC, Reimann E, Heil SH, Higgins ST. Effects of smoking cessation on illicit drug use among opioid maintenance patients: A pilot study Journal of Drug Issues. 39: 313-328.  0.72
2008 Dunn KE, Sigmon SC, Thomas CS, Heil SH, Higgins ST. Voucher-based contingent reinforcement of smoking abstinence among methadone-maintained patients: a pilot study. Journal of Applied Behavior Analysis. 41: 527-38. PMID 19192857 DOI: 10.1901/jaba.2008.41-527  0.72
2008 Dunn KE, Sigmon SC, McGee MR, Heil SH, Higgins ST. Evaluation of ongoing oxycodone abuse among methadone-maintained patients. Journal of Substance Abuse Treatment. 35: 451-6. PMID 18295434 DOI: 10.1016/j.jsat.2007.12.006  0.72
Show low-probability matches.